Effects of combined Pulsed Dye Laser and Fractional CO2 Laser treatment of burn scars and correlation with plasma levels of collagen type I, MMP-2 and TIMP-1

Burns. 2021 Sep;47(6):1342-1351. doi: 10.1016/j.burns.2020.12.011. Epub 2020 Dec 14.

Abstract

Hypertrophic burn scars remain a significant burden for patients and a challenge for clinicians.

The aim: Assessement of the efficacy of combined Pulsed Dye Laser and Ablative Fractional CO2 Laser therapy on hyperthophic scars and correlation with plasma levels of MMP-2, TIMP-1 and alpha-1 type I collagen.

Patients and methods: Twenty five pediatric subjects were enrolled into the study. Control group consisted of age-matched subjects admitted for surgical repair of inguinal hernia. For the assessment of the results of laser treatment we used the Vancouver scar scale (VSS), and Patient-Observer Scar Assessment Scale (POSAS). We also correlated clinical results with plasma levels of MMP-2, TIMP-1 and alpha-1 type I collagen.

Results: All subjects reported the laser treatment resulted in improvement and were somewhat satisfied or very satisfied with their experience. No adverse events were reported. The levels of MMP-2, TIMP-1 and alpha-1 type I collagen in our patients with scars before laser threatment were higher in comparison to controls. We also found statistically significant decrease in the levels of MMP-2, TIMP-1 and alpha-1 type I collagen after laser treatment of burn scars CONCLUSIONS: Our study clearly shows that combined CO2-AFL treatment for burn scars improve texture, colour, function and alleviate pruritus. We believe that decrease in the levels of MMP-2, TIMP-1 and alpha-1 type I collagen after laser treatment of burn scars, reflects reduced dynamic of scar.

Keywords: Burn scars; Collagen type I; Fractional CO(2) Laser; Laser treatment; MMP-2; Plasma; Pulsed Dye Laser; TIMP-1.

MeSH terms

  • Burns* / complications
  • Carbon Dioxide
  • Child
  • Cicatrix, Hypertrophic* / pathology
  • Cicatrix, Hypertrophic* / surgery
  • Collagen Type I / blood
  • Collagen Type I, alpha 1 Chain
  • Humans
  • Lasers, Dye* / therapeutic use
  • Lasers, Gas* / therapeutic use
  • Matrix Metalloproteinase 2 / blood
  • Tissue Inhibitor of Metalloproteinase-1 / blood
  • Treatment Outcome

Substances

  • COL1A1 protein, human
  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • TIMP1 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • Carbon Dioxide
  • MMP2 protein, human
  • Matrix Metalloproteinase 2